Hoth Therapeutics to Begin Production of BioLexa Therapeutic for Upcoming Toxicology and Clinical Trials Read more
Rick Thompson CEO at Findacure invitation to SMI’s Orphan Drugs & Rare Diseases Conference 2019 Read more
CStone and Bayer announce global collaboration to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib Read more
Bayer and Arvinas to Collaborate on Human PROTAC Therapies and Launch a Separate Joint Venture to Develop Agricultural PROTAC Applications Read more
Celgene and Acceleron Announce FDA Accepts Luspatercept Biologics License Application in Myelodysplastic Syndromes and Beta-Thalassemia Read more
Vertex Expands into New Disease Areas and Enhances Gene Editing Capabilities Through Expanded Collaboration with CRISPR Therapeutics and Acquisition of Exonics Therapeutics Read more